The Consortium counts on renowned research leaders in their field with international networking and project and enterprises with unique background reputation and a solid impact among researchers and professionals.
At the basic discovery level, the added value of the consortium is exceptional and counts on excellent young researchers first-time participants to FET under Horizon 2020 who proved their capability to translate visionary ideas and revolutionary materials into practice. Sound expertise on cardiac biomechanics and pathophysiology and availability of state-of- the-art technology applied to animal models and human organs as proxy of the clinical settings are ready to be implemented for the scope.
The Consortium joins academic and enterprise competence for a cross-cutting approach and effective knowledge transfer, boosting SME on polymeric materials and taking advantage of a world leading company in bioprinting to promote intersectoral mobility. Exploiting the network of a leader industry on device development regulatory processes and professionals’ involvement may allow implementing this technology to noncardiac applications beyond the consortium specialties toward a revolutionary eco-system of innovation.
The scheme below shows the main capabilities that the partners bring to REPAIR and their strong complementarity which is the base for synergic interaction.
REPAIR partners complementary capabilities in detail:
University of Florence
Italy
Background:
LCE material
Translational Cardiology
3D-Bioprinting
EU grant coordination
Main Contributions:
REPAIR Coordination and management Communication and dissemination
Basic Research: LCE development and optimization Characterization of artificial
Translational Research: Optimization and refining of all LCE-based devices
